| Literature DB >> 31618639 |
Hiroo Katsuya1, Saiful Islam1, Benjy Jek Yang Tan1, Jumpei Ito2, Paola Miyazato1, Misaki Matsuo1, Yuki Inada3, Saori C Iwase1, Yoshikazu Uchiyama4, Hiroyuki Hata5, Tomoo Sato6, Naoko Yagishita6, Natsumi Araya6, Takaharu Ueno7, Kisato Nosaka8, Masahito Tokunaga9, Makoto Yamagishi10, Toshiki Watanabe11, Kaoru Uchimaru10, Jun-Ichi Fujisawa7, Atae Utsunomiya12, Yoshihisa Yamano6, Yorifumi Satou13.
Abstract
The retrovirus human T-cell leukemia virus type 1 (HTLV-1) integrates into the host DNA, achieves persistent infection, and induces human diseases. Here, we demonstrate that viral DNA-capture sequencing (DNA-capture-seq) is useful to characterize HTLV-1 proviruses in naturally virus-infected individuals, providing comprehensive information about the proviral structure and the viral integration site. We analyzed peripheral blood from 98 naturally HTLV-1-infected individuals and found that defective proviruses were present not only in patients with leukemia, but also in those with other clinical entities. We further demonstrated that clones with defective-type proviruses exhibited a higher degree of clonal abundance than those with full-length proviruses. The frequency of defective-type proviruses in HTLV-1-infected humanized mice was lower than that in infected individuals, indicating that defective proviruses were rare at the initial phase of infection but preferentially selected during persistent infection. These results demonstrate the robustness of viral DNA-capture-seq for HTLV-1 infection and suggest potential applications for other virus-associated cancers in humans.Entities:
Keywords: DNA-capture-seq; HIV-1; HTLV-1; adult T cell leukemia-lymphoma; clonality analysis; next-generation sequencing; retroviral latency; retrovirus; viral integration site; viral oncogenesis
Year: 2019 PMID: 31618639 DOI: 10.1016/j.celrep.2019.09.016
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423